How is the Summit Therapeutics Inc today?

The Summit Therapeutics Inc today is trading in the down by -3.38% at 20.60.

How has Summit Therapeutics Inc performed historically?

The Summit Therapeutics Inc is currently trading down -3.38% on an intraday basis in the past week the index rose 0.19%. The index has been down 0.00% in the past quarter and rose 161.75% in the past year. You can view this in the overview section.

What is Summit Therapeutics Inc Annual Net Profit?

Summit Therapeutics Inc Annual Net Profit rose 64.01% in the last year to $221.32 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Summit Therapeutics Inc Price to Earning Ratio?

Summit Therapeutics Inc Price to Earning Ratio is -63.54, which is negative.

What is Summit Therapeutics Inc Stock Price?

Summit Therapeutics Inc Stock Price rose 161.75% and outperformed its sector by 126.88% in the past year.

What is Summit Therapeutics Inc Quarterly Net profit?

Summit Therapeutics Inc Quarterly Net profit fell 44.72% YoY to $62.91 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is Summit Therapeutics Inc Debt to Equity Ratio?

Summit Therapeutics Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Summit Therapeutics Inc Return on Equity(ROE)?

Summit Therapeutics Inc Return on Equity(ROE) for the last financial year was -94.9%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Summit Therapeutics Inc Mutual Fund Holding?

Summit Therapeutics Inc Mutual Fund Holding increased by 0.05% in the last quarter to 7.3.

What is Summit Therapeutics Inc Interest Coverage Ratio?

Summit Therapeutics Inc Interest Coverage Ratio is -24.48, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Summit Therapeutics Inc Institutional Holding?

Summit Therapeutics Inc Institutional Holding increased by 0.69% in the last quarter to 13.23.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
SUMMIT THERAPEUTICS INC

Summit Therapeutics Inc XNAS: SMMT

Summit Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Summit Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Summit Therapeutics Inc
Rating: 1.31716675
Author: Trendlyne DVM scores

about

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazo...

20.60 -0.72 (-3.38%)

44.19% Fall from 52W High

14.1M

XNAS Volume

High volume today

XNAS 27 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.7 / 100

Technically Neutral

52.0 / 100

No estimates available

Summit Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Summit Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazo...

44.19% Fall from 52W High

High volume today

SWOT Analysis

Summit Therapeutics Inc Live Price Chart

Summit Therapeutics Inc FAQ

How is Summit Therapeutics Inc today?

Summit Therapeutics Inc today is trading in the red, and is down by -3.38% at 20.60.

How has Summit Therapeutics Inc performed historically?

Summit Therapeutics Inc is currently trading down -3.38% on an intraday basis. In the past week the stock rose 0.19%. stock has been down 0.00% in the past quarter and rose 161.75% in the past year. You can view this in the overview section.